Stephen D. Griffin
Executive Vice President, Chief Financial Officer, and Chief Operating Officer
CFO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Anika Therapeutics, Inc. (ANIK) | President and Chief Executive Officer; Former EVP, Chief Financial Officer and Chief Operating Officer | $500,000 | $2,033,370 |
| 2024 | Anika Therapeutics, Inc. (ANIK) | EVP, Chief Financial Officer and Treasurer | $278,846 | $2,646,150 |
Executive changes
Earnings-call appearances
-
Anika Therapeutics, Inc. Q4 FY2025 Earnings Call2026-02-26
Anika Therapeutics, Inc. (ANIK)
-
Anika Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-05
Anika Therapeutics, Inc. (ANIK)
-
Anika Therapeutics, Inc. Q2 FY2025 Earnings Call2025-07-30
Anika Therapeutics, Inc. (ANIK)